Please be respectful of others' privacy, and avoid sharing personal information or sensitive content without their permission. If you are unsure if something is appropriate to share, ask for permission (use the 'Privately email' option when replying to their post) or avoid sharing it altogether.
- Manlobbi
Stocks A to Z / Stocks B / Berkshire Hathaway (BRK.A) ❤
No. of Recommendations: 0
Mungo-Buy weakness?
Not sure why getting hit
No. of Recommendations: 0
money moving back into tech stocks, I nibbled at 404 n change the other day...waiting...
No. of Recommendations: 1
$404?
BRKB or HSY?
No. of Recommendations: 1
speaking of charts, more ugly.
No. of Recommendations: 10
Not sure why getting hit
There was another downgrade, the price has been falling for a while, management's outlook for the year was poor, and the high cocoa prices are a good narrative for traders.
As you can imagine, I'm pretty stubborn about my opinions, so I'm not selling. Even through the high cocoa prices are actually an issue, not just a story.
I waited a number of years for what I thought was a good entry. In that situation I don't sweat too hard about the (usually transient) bad news that dominates at such times.
Jim
No. of Recommendations: 0
NSRGY looking pretty oversold on a 1 year and 3 year basis too
No. of Recommendations: 0
Looks like it will try to test the 12/20/23 close at 179.52 soon. Could make a nice double bottom.
That being said, it is in a nasty downtrend. I think a major fear is that the GLP-1 drugs will slow down consumer snacking. That is hard for me to believe, but I will wait for a solid bottom before buying.
No. of Recommendations: 1
NSRGY one of the great all time Co's. NEVER cheap
No. of Recommendations: 0
sorry , brkb
No. of Recommendations: 10
NSRGY one of the great all time Co's. NEVER cheap
Let's see.
It's up a whopping 9% over 5 years.
38% over 10 years.
210% over 15 years.
308% over 20 years.
We must have different definitions of great.
No. of Recommendations: 1
No. of Recommendations: 0
NSRGY looks like a fat pitch too JIM?
No. of Recommendations: 1
I think a major fear is that the GLP-1 drugs will slow down consumer snacking. That is hard for me to believe, but I will wait for a solid bottom before buying.
I would love to hear a quantitative analysis of how GLP-1 drugs could be a threat to the likes of Hershey, Coca-Cola, Pepsi, etc. But like you, I am skeptical - it is very hard for me to believe this will be an issue for any significant volume of sales.
dtb
No. of Recommendations: 5
Charlie: NSRGY one of the great all time Co's. NEVER cheap
carolsharp: Let's see........ We must have different definitions of great.
I am with Charlie. Nestle is one of the most reliable dividend payers in the world (currently >3%). Include those and your numbers look very different.
Charlie is absolutely right, it's one of the rare great all time companies, and it's never cheap - - - but clearly less expensive now than usually. As I waited many years for that to happen I bought a little last week, this week, and will continue.
No. of Recommendations: 0
NSRGY looks like a fat pitch too JIM?
If I am not mistaken he wrote something that he bought too, for $96 or so - - - clearly "overpaying" (I paid $92 :-)
No. of Recommendations: 8
I would love to hear a quantitative analysis of how GLP-1 drugs could be a threat to the likes of Hershey, Coca-Cola, Pepsi, etc
I am more than dubious.
If I were taking a drug that made me skinnier, I would eat more chocolate, not less, for sure. Whether it reduced appetite or not: chocolate isn't something I eat based on hunger!
As it happens, I just had some outstanding extra-high-cocoa-content Ducasse milk chocolate. Even though I'm not a milk chocolate kind of person....ahhhh.
Jim
No. of Recommendations: 11
carolsharp: Let's see........ We must have different definitions of great.
In terms of stock market returns (certainly not a metric of value), it's far from a loser.
One could characterize Nestle's returns as follows--
Hugely outperformed the average S&P 500 firms 2006-2009. Very much in fashion!
Did about as well as the average S&P 500 firm 2009-2013.
A modest relative slide 2013-2017, say a one time slide of 15% or so, undoing around half the relative-to-S&P boost from 2006-2009.
Roughly tracking the average S&P 500 firm 2017 till the middle of last year.
Then a pretty sudden drop of about 22% leading to the recent "cheaper than usual" situation.
Even at the current seemingly depressed price level (temporarily??), it has nicely outperformed the average S&P 500 firm since any time in the 2003-2006 stretch.
I don't have data handy for any time before that.
Performance notes are based on total return including dividends.
Jim
No. of Recommendations: 0
They own a stake in Loreal too.
No. of Recommendations: 0
No. of Recommendations: 5
No. of Recommendations: 3
Swiss chocolatier Lindt seems to be doing fine, high cocoa prices and other sources of inflation not withstanding. Being a premium brand compared to Hershey and Nestle, gives them much greater pricing power. But PE of 40 is double that of Hershey and Nestle.
I usually grab a packet of truffles on my monthly Costco expedition. Much more delicious than anything Hershey, Nestle or Mars offers.
The Swiss chocolatier said on Tuesday that it increased its full-year net profit by 18% to 671.4 million Swiss francs ($758.6 million) compared with the prior year, which it attributed to price increases as a result of higher raw-material prices and inflationary pressure.
Earnings before interest and taxes increased 9.2% to CHF813.1 million, with a margin that expanded to 15.6% from 15.0%.
The company confirmed its preliminary sales figures published in January, which showed sales grew 10% organically, as well as its 2024 guidance.https://www.morningstar.com/news/dow-jones/2024030...
